Concordance of FDG PET/CT metabolic tumour volume versus DW-MRI functional tumour volume with T2-weighted anatomical tumour volume in cervical cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Concordance of FDG PET/CT metabolic tumour volume versus DW-MRI functional tumour volume with T2-weighted anatomical tumour volume in cervical cancer ; volume:17 ; number:1 ; day:6 ; month:12 ; year:2017 ; pages:1-8 ; date:12.2017
BMC cancer ; 17, Heft 1 (6.12.2017), 1-8, 12.2017
- Creator
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12885-017-3800-9
- URN
-
urn:nbn:de:101:1-2019061421580990612562
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:54 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lai Yee Tak, Alta
- Perucho, Jose A. U.
- Xu, Xiaopei
- Hui, Edward S.
- Lee, Elaine Y. P.
- SpringerLink (Online service)
Other Objects (12)
Estimation of tumour volume at therapy initiation by back-extrapolating the post-therapy regression curve of tumour volume
Repeatability of [18F]FDG PET/CT total metabolic active tumour volume and total tumour burden in NSCLC patients
Breast and Tumour Volume Measurements in Breast Cancer Patients Using 3-D Automated Breast Volume Scanner Images
Size matters: integrating tumour volume and immune activation signatures predicts immunotherapy response
The significance of partial volume effect on the estimation of hypoxic tumour volume with [18F]FMISO PET/CT
The impact of MRI sequence on tumour staging and gross tumour volume delineation in squamous cell carcinoma of the anal canal
PrognosiT: Pathway/gene set-based tumour volume prediction using multiple kernel learning
Gross tumour volume radiomics for prognostication of recurrence & death following radical radiotherapy for NSCLC
Use of Imaging to Optimise Prostate Cancer Tumour Volume Assessment for Focal Therapy Planning
Clinically feasible semi-automatic workflows for measuring metabolically active tumour volume in metastatic melanoma
Harmonization of nomenclature for molecular imaging metrics of tumour burden: molecular tumour volume (MTV), total lesion activity (TLA) and total lesion fraction (TLF)
Large tumour volume reduction of IDH-mutated anaplastic glioma involving the insular region following radiotherapy
Estimation of tumour volume at therapy initiation by back-extrapolating the post-therapy regression curve of tumour volume
Repeatability of [18F]FDG PET/CT total metabolic active tumour volume and total tumour burden in NSCLC patients
Breast and Tumour Volume Measurements in Breast Cancer Patients Using 3-D Automated Breast Volume Scanner Images
Size matters: integrating tumour volume and immune activation signatures predicts immunotherapy response
The significance of partial volume effect on the estimation of hypoxic tumour volume with [18F]FMISO PET/CT
The impact of MRI sequence on tumour staging and gross tumour volume delineation in squamous cell carcinoma of the anal canal
PrognosiT: Pathway/gene set-based tumour volume prediction using multiple kernel learning
Gross tumour volume radiomics for prognostication of recurrence & death following radical radiotherapy for NSCLC
Use of Imaging to Optimise Prostate Cancer Tumour Volume Assessment for Focal Therapy Planning
Clinically feasible semi-automatic workflows for measuring metabolically active tumour volume in metastatic melanoma
Harmonization of nomenclature for molecular imaging metrics of tumour burden: molecular tumour volume (MTV), total lesion activity (TLA) and total lesion fraction (TLF)
Large tumour volume reduction of IDH-mutated anaplastic glioma involving the insular region following radiotherapy
Estimation of tumour volume at therapy initiation by back-extrapolating the post-therapy regression curve of tumour volume
Repeatability of [18F]FDG PET/CT total metabolic active tumour volume and total tumour burden in NSCLC patients
Breast and Tumour Volume Measurements in Breast Cancer Patients Using 3-D Automated Breast Volume Scanner Images
Size matters: integrating tumour volume and immune activation signatures predicts immunotherapy response
The significance of partial volume effect on the estimation of hypoxic tumour volume with [18F]FMISO PET/CT
The impact of MRI sequence on tumour staging and gross tumour volume delineation in squamous cell carcinoma of the anal canal
PrognosiT: Pathway/gene set-based tumour volume prediction using multiple kernel learning
Gross tumour volume radiomics for prognostication of recurrence & death following radical radiotherapy for NSCLC
Use of Imaging to Optimise Prostate Cancer Tumour Volume Assessment for Focal Therapy Planning
Clinically feasible semi-automatic workflows for measuring metabolically active tumour volume in metastatic melanoma
Harmonization of nomenclature for molecular imaging metrics of tumour burden: molecular tumour volume (MTV), total lesion activity (TLA) and total lesion fraction (TLF)